Nevertheless, the small number of TNBC (n = 34) and HER2 (n = 36) cases in our cohort, and the absence of information about PFS and MFS in the publicly available TCGA-BRCA dataset cannot completely exclude such a role in these breast cancer subgroups. This evidence concerns the gene ERBB2 and breast cancer.